AViTA Corporation (TPEX:4735)
Taiwan · Delayed Price · Currency is TWD 34.40
0.00 (0.00%)
Sep 12, 2025, 1:30 PM CST
AViTA Market Cap
AViTA has a market cap or net worth of 1.32 billion as of September 12, 2025. Its market cap has decreased by -13.22% in one year.
Market Cap
1.32B
Enterprise Value
805.29M
Revenue
929.79M
Ranking
n/a
PE Ratio
17.61
Stock Price
34.40
Market Cap Chart
Since April 27, 2010, AViTA's market cap has increased from 776.16M to 1.32B, an increase of 70.66%. That is a compound annual growth rate of 3.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.32B | -3.21% |
| Dec 31, 2024 | 1.37B | 1.74% |
| Dec 29, 2023 | 1.35B | -6.91% |
| Dec 30, 2022 | 1.45B | -32.68% |
| Dec 30, 2021 | 2.15B | -42.25% |
| Dec 31, 2020 | 3.72B | 154.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 321.06B |
| PharmaEssentia | 184.18B |
| Bora Pharmaceuticals Co., LTD. | 87.74B |
| Lotus Pharmaceutical | 48.91B |
| Lumosa Therapeutics | 46.66B |
| Oneness Biotech | 34.72B |
| Polaris Group | 29.12B |
| Center Laboratories | 27.50B |